Yousif Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CIM
RP
IHL
CPCPP
P
CNB
CCMINC
Yousif Capital Management's CRL Position: Q2 2026 in Review
Yousif Capital Management increased its Charles River Laboratories (CRL) stake by 0.82% in Q2 2026, buying an estimated $7.66K and bringing the position to 5,277 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #960.
Yousif Capital Management first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.44M in Q4 2021. 81 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Yousif Capital Management held 5,277 shares of Charles River Laboratories worth $1.2M as of Q2 2026.
- Yousif Capital Management bought 43 Charles River Laboratories shares in Q2 2026, an estimated $7.66K.
- Charles River Laboratories made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #960 holding.
- Yousif Capital Management first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
- Yousif Capital Management's Charles River Laboratories position peaked at $3.44M in Q4 2021.
- 81 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.